Home » Topics » BioWorld Science

BioWorld Science
RSS

Continued progress in clinical programs reported at Guilford

Aug. 29, 2001

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

Aug. 29, 2001

Crucell establishes human antibody agreement with Centocor for treatment of cancer

Aug. 29, 2001

A promising scaffold for bioartificial liver development

Aug. 29, 2001

Neurocrine Biosciences expands clinical development efforts during Q2

Aug. 29, 2001

Novartis files FDA application for Zometa as treatment for bone metastases

Aug. 29, 2001

Dexmethylphenidate hydrochloride receives FDA approvable letter for ADHD

Aug. 29, 2001

Phase II trial of MG-98 in renal cell carcinoma begins

Aug. 29, 2001

Avax granted licensing option for SCID gene therapy technology

Aug. 29, 2001

Efexor XR, a long-term alternative to benzodiazepines in treating anxiety

Aug. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...